Results 11 to 20 of about 209,409 (314)

Balloon pulmonary angioplasty – efficient therapy of chronic thromboembolic pulmonary hypertension in the patient with advanced sarcoidosis – a case report

open access: yesBMC Pulmonary Medicine, 2018
Background Approximately a quarter of patients with advanced sarcoidosis develop pulmonary hypertension (PH), which affects their prognosis. We report unusual case of confirmed chronic thromboembolic pulmonary hypertension (CTEPH) in a patient with stage
Andrzej Labyk   +10 more
doaj   +1 more source

Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]

open access: yes, 2017
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

open access: yes, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M   +36 more
core   +1 more source

Thromboembolism [PDF]

open access: yesBritish Medical Bulletin, 2003
Venous thomboembolism (VTE) causes only about 2% of maternal deaths in the developing world but is a leading cause of direct maternal deaths in developed countries. Pregnancy increases the risk of VTE through venous stasis, changes in blood coagulability and damage to vessels.
openaire   +2 more sources

Evaluation of an Unfractioned Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients [PDF]

open access: yes, 2017
Background: Despite large interpatient variability in dose response, heparin is utilized for treatment of venous thromboembolism (VTE). Current data on the optimal heparin dosing in obese patients are conflicting. Objective: The objective was to evaluate
Breedlove, Emily Y.   +3 more
core   +2 more sources

Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature

open access: yesCase Reports in Hematology, 2017
Background. Hereditary antithrombin deficiency is a thrombogenic disorder associated with a 50–90% lifetime risk of venous thromboembolism (VTE), which is increased during pregnancy and the puerperium in these patients.
Mohammad Refaei   +4 more
doaj   +1 more source

The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists

open access: yesCardiology Journal, 2020
In patients diagnosed with chronic kidney disease (CKD), atrial fibrillation (AF) is associated with an increased risk of thromboembolism and stroke. Moreover, patients with CKD — especially those in end-stage renal disease — also present an increased ...
Justyna Domienik-Karłowicz   +4 more
doaj   +1 more source

Multiorgan Visceral Hemangiomas Presenting with Sequential Ruptures and Hemorrhage, Cardiac Thrombus, and Thromboembolic Phenomenon

open access: yesJournal of Gastrointestinal and Abdominal Radiology, 2023
Vascular anomalies can be seen in a disseminated or diffuse state to involve multiple superficial and deep sites. Large and diffuse lesions are known to induce a hemorrhagic tendency.
Subhash Kumar   +3 more
doaj   +1 more source

Extended thromboprophylaxis with betrixaban in acutely ill medical patients [PDF]

open access: yes, 2016
BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown.
. Lodigiani, M   +18 more
core   +1 more source

Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors

open access: yesTH Open, 2022
Heparin has already been found in a variety of animal tissues but only few of them became effective sources for production of pharmaceutical preparations.
Stephan N.M.C.G. Oliveira   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy